A bacterium capable of predicting the course of a disease

PRESS RELEASE - Solving problems by harnessing the natural adaptive capacity of bacteria. This is the challenge taken up by a research team coordinated by INRAE and involving Grenoble Alpes University Hospital, Université Grenoble Alpes and the French Alternative Energies and Atomic Energy Commission (CEA). By tracking the growth curves of the bacterium Escherichia coli, the researchers were able to distinguish between mild and severe forms of COVID-19. These results, published in Cell Systems, pave the way for simple and low-cost diagnostic methods.

Published on 02 July 2026

© NIAD

Information processing using living organisms is an important area of biotechnology that has already been explored in previous studies1

A research team coordinated by INRAE and involving Grenoble Alpes University Hospital, Université Grenoble Alpes and the CEA made use of the bacterium's natural capabilities without altering it genetically. Using plasma samples from patients with COVID-19, the scientists were able to distinguish patients likely to develop a mild form of the disease from those at risk of progressing to a severe form.

To achieve this, the researchers harnessed the bacterium's natural ability to adapt—in this case, Escherichia coli. The bacterium did not evolve to perform computations, but to survive. In its environment, it must constantly detect signals: which nutrients are present, in what quantities, and how these conditions change over time. In response, it adjusts its metabolism and growth. Rather than viewing bacterial growth simply as a biological phenomenon, the scientists use it for information processing.

How does it work? In the case of the clinical samples, the bacterium is placed directly in contact with patients' plasma. It responds to the plasma's chemical composition by growing faster or more slowly, generating a growth curve that reflects all the signals it has detected. For other computational tasks described in the article, the problem is first translated into a nutrient mixture, and the bacterium responds in exactly the same way—through its pattern of growth. In both cases, the resulting growth curve is then measured and used to generate an answer—for example, to classify a sample into one category rather than another, in this case according to the risk of developing a mild or severe form of COVID-19. Remarkably, a bacterium that has never been trained is able to perform tasks that are normally assigned to machine learning algorithms.

This approach could lead to simple, affordable diagnostic and prognostic tools that can be deployed even where technical resources are limited. The research team now plans to explore other applications, such as monitoring environmental samples, particularly urban wastewater, or analysing other types of clinical samples. More broadly, the study points to a new possibility: using genetically unmodified living organisms as systems capable of converting the complexity of a sample into usable information.

1. Pandi A., Koch M., Voyvodic P.L. et al. (2019). Metabolic Perceptrons for Neural Computing in Biological Systems. Nature Communications, https://doi.org/10.1038/s41467-019-11889-0

reference

Ahavi P., Hoang T. N. A., Meyer P. et al. (2026). Living Bacterial Reservoir Computers for Information Processing and Sensing. Cell Systems, DOI: https://doi.org/10.1016/j.cels.2026.101654

scientific contact

Jean-Loup Faulon

Joint research unit Microbiology of Food for Health (INRAE, AgroParisTech, université Paris-Saclay)

Centre

Division

Learn more

Food, Global Health

A probiotic bacterial strain proven more effective for treating a common intestinal infection

PRESS RELEASE - Giardiasis is a common intestinal parasitic infection affecting both humans and animals. The infection is caused by the parasite Giardia intestinalis and diarrhoea and abdominal pain are among its common symptoms. INRAE, MNHN and EnvA, in collaboration with Boehringer Ingelheim Animal Health (BIAH), selected a strain of the probiotic bacterium Lactobacillus johnsonii CNCM I-4884, with enhanced anti-Giardia activity. The scientists tested the new strain in animals and found that it was more resistant to digestive processes and 15% more effective against the parasite itself.

26 March 2025

Biodiversity

Architect bacteria build networked membranous structures to improve nutrition

PRESS RELEASE - The cereal weevil, a major crop pest, provides a home for symbiotic bacteria within the cells of its body. Scientists from INRAE and INSA Lyon, working with experts from Synchroton SOLEIL and Claude Bernard University in France and with the Max Planck Institute and the European Molecular Biology Laboratory in Germany, have discovered that these bacteria build networks of complex membranous structures inside the host cell, increasing the area of the exchange interface to actively retrieve an essential nutrient – sugar.

28 October 2025

Food, Global Health

Viral blood signature discovered for Crohn’s disease

PRESS RELEASE - Viruses that infect bacteria (known as bacteriophages), are present in the blood of all humans, a fact confirmed by scientists from INRAE, Sorbonne University and AP-HP.  In a novel comparative study of blood samples from patients with Crohn’s disease and a healthy control group, they have detected a distinctive profile of bacteriophages that can provide a signature for this condition. The results are published in Gastoenterology.

29 December 2025